This 2015 preclinical paper examines the pharmacological mechanisms mediated by BSE, in protecting intestinal epithelial barrier from inflammatory damage and supports its use as a safe adjuvant in patients affected by IBD. Fortification of the intestinal barrier function is still a challenge in acute or chronic colonic cell lines and supplementation with Boswellia demonstrated key cellular changes that restored function.
References:
Catanzaro, D., Rancan, S., Orso, G., Dall’Acqua, S., Brun, P., Giron, M. C., Carrara, M., Castagliuolo, I., Ragazzi, E., Caparrotta, L., & Montopoli, M. (2015). Boswellia serrata Preserves Intestinal Epithelial Barrier from Oxidative and Inflammatory Damage. PloS one, 10(5), e0125375. https://doi.org/10.1371/journal.pone.0125375